{"database": "lobbying", "table": "lobbying_activities", "rows": [[1738955, "93613ec1-795a-4338-967c-53334ee617ad", "Q3", "SLC HEALTH STRATEGIES, LLC", 401018877, "NOVO NORDISK PHARMACEUTICALS, INC.", 2015, "third_quarter", "PHA", "HR 6 - 21st Century Cures Act\nFDA issues regarding biosimilar products; 340B program matters", "HOUSE OF REPRESENTATIVES,SENATE", 22500, null, 0, 0, "2015-10-19T13:45:27.897000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1738955"], "units": {}, "query_ms": 37.55274199647829, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}